Gene changes driving myopia reveal new focus for drug development

Myopia (nearsightedness) and hyperopia (farsightedness) develop through different molecular pathways, according to a new study. The finding provides a new understanding of myopia, the most common form of visual impairment worldwide, and opens the way for development of drugs to prevent it.

Source: sciencedaily.com

Related posts

Better medical record-keeping needed to fight antibiotic overuse

Global life expectancy to increase by nearly 5 years by 2050 despite geopolitical, metabolic, and environmental threats

Modern plant enzyme partners with surprisingly ancient protein